193 related articles for article (PubMed ID: 29563635)
1. In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics.
McNamara KM; Guestini F; Sauer T; Touma J; Bukholm IR; Lindstrøm JC; Sasano H; Geisler J
Br J Cancer; 2018 May; 118(9):1208-1216. PubMed ID: 29563635
[TBL] [Abstract][Full Text] [Related]
2. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
3. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen producing enzymes and mammary carcinogenesis: a review.
Subramanian A; Salhab M; Mokbel K
Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6.
Speirs V; Walton DS; Hall MC; Atkin SL
Br J Cancer; 1999 Oct; 81(4):690-5. PubMed ID: 10574257
[TBL] [Abstract][Full Text] [Related]
6. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
Sang X; Han H; Li T; Lin SX
J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
[TBL] [Abstract][Full Text] [Related]
7. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
8. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
[TBL] [Abstract][Full Text] [Related]
9. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
[TBL] [Abstract][Full Text] [Related]
10. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
[TBL] [Abstract][Full Text] [Related]
11. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M
Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726
[TBL] [Abstract][Full Text] [Related]
12. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
Zhou N; Han SY; Zhou F; Li PP
J Ethnopharmacol; 2014 Jul; 154(3):687-95. PubMed ID: 24809288
[TBL] [Abstract][Full Text] [Related]
14. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors.
Calvillo-Robledo A; Pedernera E; Morales-Vásquez F; Pérez-Montiel D; Gómora MJ; Almaraz MÁ; de Alba Graue PG; Rendón E; López-Basave HN; Quintanar-Stephano A; Méndez C
J Ovarian Res; 2021 Jul; 14(1):98. PubMed ID: 34321053
[TBL] [Abstract][Full Text] [Related]
17. Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer.
Yoshimura N; Harada N; Bukholm I; Kåresen R; Børresen-Dale AL; Kristensen VN
Breast Cancer Res; 2004; 6(2):R46-55. PubMed ID: 14979917
[TBL] [Abstract][Full Text] [Related]
18. Intracrine mechanism of estrogen synthesis in breast cancer.
Suzuki T; Moriya T; Ishida T; Ohuchi N; Sasano H
Biomed Pharmacother; 2003 Dec; 57(10):460-2. PubMed ID: 14637389
[TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.
Yoda T; McNamara KM; Miki Y; Takagi M; Rai Y; Ohi Y; Sagara Y; Tamaki K; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
Cancer Sci; 2014 Nov; 105(11):1503-9. PubMed ID: 25230018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
